Quick Answer: Peptides are short chains of amino acids that act as signaling molecules in the body. Some — like tesamorelin and bremelanotide — are FDA-approved pharmaceuticals with real clinical data. Others — like BPC-157 and Epithalon — show promise in animal studies but lack human trials. This guide covers 13 peptides across healing, longevity, growth hormone, immune, and metabolic categories, with honest assessments of the evidence for each.
Peptides have gone from niche biohacking curiosity to mainstream health conversation in just a few years. Google searches for peptide-related terms now exceed 500,000 per month in the US alone. Anti-aging clinics prescribe them. Athletes use them for recovery. Longevity researchers study them as potential interventions against aging itself.
The problem? The marketing has outpaced the science for most of them. Vendor websites cite animal studies as if they’re proven human therapies. Social media influencers promote peptide stacks with zero clinical validation. And the regulatory landscape is a patchwork of FDA-approved drugs, compounding pharmacy preparations, and unregulated research chemicals — all sold under the same “peptide” umbrella.
This guide cuts through the noise. We’ve written detailed, evidence-based articles on 13 peptides, organized by category. For each one, we assess the actual strength of evidence, not just the hype.
How to Use This Guide
Each peptide below links to a full article with mechanism of action, research evidence, dosing from studies, safety considerations, and legal status. We’ve organized them by primary use category, though many peptides cross multiple categories.
Evidence ratings used below:
- 🟢 Strong — FDA-approved or multiple human RCTs
- 🟡 Moderate — Some human data or strong animal evidence with plausible mechanism
- 🔴 Early — Mostly animal/cell studies, limited or no human clinical data
Healing and Recovery Peptides
These peptides target tissue repair, wound healing, and recovery from injury.
BPC-157 — The Gut Healing Peptide
Evidence: 🔴 Early (strong animal data, minimal human)
BPC-157 (Body Protection Compound-157) is a synthetic gastric pentadecapeptide with remarkable healing properties in animal models — gut ulcers, tendon injuries, nerve damage, and more. It’s the most-searched non-weight-loss peptide at ~165,000 monthly US searches. The catch: almost all evidence comes from rodent studies, with no large human RCTs published.
TB-500 — Thymosin Beta-4 for Tissue Repair
Evidence: 🔴 Early (animal data, banned in sports)
TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring protein involved in cell migration, angiogenesis, and wound healing. Animal studies show impressive results for cardiac repair, tendon recovery, and wound healing. It’s frequently stacked with BPC-157 in biohacking circles, though that combination has zero clinical validation. Banned by WADA.
Growth Hormone Peptides
These peptides stimulate the body’s own growth hormone production rather than injecting synthetic HGH directly.
Tesamorelin — FDA-Approved GHRH Analog
Evidence: 🟢 Strong (FDA-approved, multiple RCTs)
Tesamorelin (Egrifta) is the only FDA-approved growth hormone-releasing hormone analog, indicated for HIV-associated lipodystrophy. It stimulates pulsatile GH release from the pituitary while preserving the body’s natural feedback loop. Widely used off-label in anti-aging clinics for visceral fat reduction and body composition improvement.
Read the full Tesamorelin guide →
CJC-1295 + Ipamorelin — The Popular GH Stack
Evidence: 🟡 Moderate (individual components studied, stack not validated)
The most commonly prescribed peptide combination in anti-aging clinics. CJC-1295 (a long-acting GHRH analog) provides sustained GH elevation while Ipamorelin (a selective ghrelin mimetic) triggers acute GH pulses. Each has individual clinical data, but the combination protocol is based on clinical practice rather than RCTs.
Read the full CJC-1295 + Ipamorelin guide →
Sermorelin — The Original GH Peptide
Evidence: 🟢 Strong (formerly FDA-approved, extensive clinical use)
Sermorelin was FDA-approved in 1997 as Geref for growth hormone deficiency. Though voluntarily withdrawn from the commercial market in 2008, it remains widely available through compounding pharmacies and is considered one of the safer GH-stimulating peptides because it preserves the pituitary’s natural feedback mechanism.
Read the full Sermorelin guide →
Longevity and Anti-Aging Peptides
These peptides target fundamental aging mechanisms — telomeres, mitochondria, cellular senescence, and metabolic decline.
MOTS-c — The Mitochondrial Exercise Mimetic
Evidence: 🔴 Early (exciting animal data, very limited human)
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA, discovered in 2015 by Changhan David Lee at USC. It activates AMPK, improves insulin sensitivity, and mimics some effects of exercise at the cellular level. MOTS-c levels decline with age, and exercise naturally increases them. The longevity research community is genuinely excited about this one, but it’s still almost entirely preclinical.
Epithalon — The Telomere Peptide
Evidence: 🔴 Early (mostly Russian research, no Western RCTs)
Epithalon (AEDG tetrapeptide) was developed by Russian gerontologist Vladimir Khavinson and has shown telomerase activation and lifespan extension in rodent studies. It also appears to restore pineal gland melatonin production. The biohacker community loves it, but the evidence base is narrow — mostly from a single research group with limited independent replication.
Read the full Epithalon guide →
SS-31 (Elamipretide) — Mitochondrial Membrane Protector
Evidence: 🟡 Moderate (multiple Phase II/III trials, mixed results)
SS-31 is a synthetic tetrapeptide that selectively targets cardiolipin in the inner mitochondrial membrane, stabilizing cristae structure and improving electron transport efficiency. It’s in clinical development by Stealth BioTherapeutics for Barth syndrome (FDA Fast Track), heart failure, and mitochondrial myopathy. Not a supplement — this is a pharmaceutical in active clinical trials.
Read the full SS-31/Elamipretide guide →
Immune Peptides
Thymosin Alpha-1 — The Immune Modulator
Evidence: 🟢 Strong (approved in 35+ countries, Phase III data)
Thymosin Alpha-1 (Zadaxin/thymalfasin) is a 28-amino-acid peptide that enhances T-cell function, dendritic cell activation, and toll-like receptor signaling. It’s approved in over 35 countries for hepatitis B and C treatment — though notably not FDA-approved in the US. It has the most robust clinical evidence of any peptide on this list outside of FDA-approved drugs.
Read the full Thymosin Alpha-1 guide →
Metabolic and Weight Loss Peptides
Retatrutide — The Next-Gen Triple Agonist
Evidence: 🟡 Moderate (impressive Phase II data, Phase III ongoing)
Retatrutide is Eli Lilly’s experimental triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 trials showed up to 24% body weight loss — surpassing both semaglutide and tirzepatide. It’s not a supplement; it’s a pharmaceutical in clinical development that could reshape obesity treatment if Phase III results hold up.
Read the full Retatrutide guide →
Skin and Cosmetic Peptides
GHK-Cu — The Copper Peptide
Evidence: 🟡 Moderate (topical clinical data, limited systemic data)
GHK-Cu is a naturally occurring copper tripeptide found in human blood plasma. It modulates gene expression affecting collagen synthesis, inflammation, and wound healing. As a topical, it has real clinical evidence for skin rejuvenation. The injectable/systemic use case is far less studied. Levels decline significantly with age — from ~200 ng/mL at age 20 to ~80 ng/mL by age 60.
Melanocortin Peptides
PT-141 (Bremelanotide/Vyleesi) — FDA-Approved for HSDD
Evidence: 🟢 Strong (FDA-approved 2019)
PT-141 is the legitimate pharmaceutical descendant of Melanotan II research. FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women, it works through melanocortin receptor activation in the CNS — a completely different mechanism from PDE5 inhibitors like Viagra. Adoption has been slower than expected due to 40% nausea rates and the self-injection requirement.
Read the full PT-141/Bremelanotide guide →
Melanotan II — A Safety Warning
Evidence: 🔴 Early (not approved anywhere, significant safety concerns)
Melanotan II is included here not as a recommendation but as a safety resource. This synthetic alpha-MSH analog causes tanning without sun exposure and has sexual side effects that drive underground demand. It is not approved in any country, has been flagged by the FDA, and carries real risks including melanoma concern, cardiovascular effects, and contamination from unregulated manufacturing.
Read the full Melanotan II safety guide →
The Big Picture: What’s Real and What’s Hype
If you take nothing else from this guide, remember these three things:
1. The evidence gap is real. Only a handful of peptides — tesamorelin, sermorelin, thymosin alpha-1, PT-141 — have substantial human clinical data. Most of the exciting results come from animal studies that may or may not translate to humans.
2. “Peptide” is not a quality category. It’s a molecular description. Some peptides are FDA-approved drugs with Phase III trial data. Others are research chemicals sold in vials with no quality assurance. Lumping them together is like comparing aspirin to an experimental compound because both are “small molecules.”
3. The regulatory landscape matters. Understanding whether a peptide is FDA-approved, available through compounding pharmacies, or only obtainable as a “research chemical” tells you a lot about how much clinical validation it has received. Generally: more regulation = more human data = more confidence in safety.
We’ll continue updating this guide as new clinical data emerges. Peptide research is moving fast, and several compounds currently in the “early evidence” category could move to “moderate” or “strong” within the next few years.
This guide is for informational purposes only and is not medical advice. Peptides with clinical applications should only be used under the supervision of a qualified healthcare provider. Never purchase unregulated research chemicals for self-administration.
Sources
- Sikiric P, et al. (2018). Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications. Curr Neuropharmacol, 16(5):446-454.
- Falutz J, et al. (2007). Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med, 357(23):2359-2370.
- Khavinson VK, et al. (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med, 135(6):590-592.
- Lee C, et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab, 21(3):443-454.
- Goldstein AL, et al. (2009). Thymalfasin: chemistry, activity, and clinical applications. Expert Opin Biol Ther, 9(5):593-608.
- Jastrzebska B, et al. (2009). GHK-Cu peptide molecular complexes and their copper-dependent effects. J Inorg Biochem, 103(11):1571-1579.
- Kingsberg SA, et al. (2019). Bremelanotide for the treatment of hypoactive sexual desire disorder. Obstet Gynecol, 134(5):899-908.
Leave a Reply